{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT00968669: Phase 2 Interventional Completed Asthma
(2009)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03647358: Phase 1 Interventional Recruiting Thyroid Carcinoma
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01040000: Phase 1/Phase 2 Interventional Completed Metastatic Pancreatic Cancer
(2012)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01284062: Phase 2 Interventional Completed Colitis, Ulcerative
(2011)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00742443: Phase 3 Interventional Completed Cicatrix
(2008)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:sothrombomodulin alfa [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04673591: Phase 2 Interventional Completed Allergy to House Dust Mite
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03622658: Phase 2 Interventional Completed Axial Spondyloarthritis
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00954642: Phase 1 Interventional Completed Solid Cancers
(2009)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00962832: Phase 2 Interventional Completed Systemic Lupus Erythematosus
(2009)
Source URL:
Class:
PROTEIN